Skip to main content
Medical information Clinical review pending

Genetic Testing

USF1 Gene Hyperlipidemia Familial Combined Susceptibility to Genetic Test

Genetic test to identify predisposition to familial combined hyperlipidemia by analyzing the USF1 gene. Helps individuals with a family history of metabolic disorders understand their risk.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube). Confirm specific requirements with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is typically required for this blood test. However, confirm with the laboratory for any specific instructions.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the USF1 Gene Hyperlipidemia Familial Combined Susceptibility to Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of hyperlipidemia
  • ✓Family history of early-onset cardiovascular disease
  • ✓Personal history of high cholesterol or triglycerides
  • ✓Individuals seeking to understand genetic risk for metabolic disorders
  • ✓Patients considering preventative cardiovascular health strategies
02

In plain language

What this test helps you understand

Identifies genetic predisposition to familial combined hyperlipidemia. Helps assess risk for cardiovascular disease based on genetic factors. Guides lifestyle and potential medical management strategies.
The USF1 Gene Hyperlipidemia Familial Combined Susceptibility to NGS Genetic DNA Test is a genetic analysis designed to identify specific variations in the USF1 gene. These variations can indicate an increased risk of developing familial combined hyperlipidemia, a condition characterized by high levels of cholesterol and/or triglycerides. This test uses Next-Generation Sequencing (NGS) technology for accurate analysis. Understanding your genetic predisposition can empower you and your healthcare provider to make informed decisions about managing your health, particularly regarding cardiovascular risk. This test is particularly relevant for individuals with a family history of high cholesterol, triglycerides, or early-onset heart disease.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is typically required for this blood test. However, confirm with the laboratory for any specific instructions.
SampleBlood sample (EDTA tube). Confirm specific requirements with the laboratory before booking.
MethodologyNext-Generation Sequencing (NGS) analysis of the USF1 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies specific genetic variations in the USF1 gene associated with hyperlipidemia risk. It does not guarantee the development of the condition, nor does it rule it out entirely. Other genetic and environmental factors also play a role. Results should be interpreted in conjunction with clinical findings and family history.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Familial combined hyperlipidemia is a common genetic disorder characterized by high levels of cholesterol and/or triglycerides in the blood, increasing the risk of heart disease.
This test is often recommended for individuals with a family history of high cholesterol, high triglycerides, or early heart disease.
The test involves analyzing a blood sample for specific genetic variations in the USF1 gene using Next-Generation Sequencing (NGS).
Results indicate the presence or absence of specific USF1 gene variations associated with hyperlipidemia risk. A healthcare provider or genetic counselor should interpret these results in the context of your personal and family health history.
No, the test identifies genetic predisposition, not certainty. Lifestyle, diet, and other genes also influence whether someone develops the condition.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp